Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1980-05-16
1981-07-28
Breitenstein, G. T.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424318, 424319, 424316, 424280, A61K 31245, A61K 31195
Patent
active
042810183
ABSTRACT:
This disclosure describes novel 4-[(carboxyl- and sulfamyl-substituted alkyl)amino]benzoic acids and analogs which are useful as hypolipidemic and antiatherosclerotic agents.
REFERENCES:
patent: 4207341 (1980-06-01), Hubner et al.
patent: 4223039 (1980-09-01), Rose et al.
American Cyanamid Company
Breitenstein G. T.
Raymond Robert P.
LandOfFree
Novel 4-[(carboxyl- and sulfamyl-substituted alkyl)-amino]benzoi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel 4-[(carboxyl- and sulfamyl-substituted alkyl)-amino]benzoi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel 4-[(carboxyl- and sulfamyl-substituted alkyl)-amino]benzoi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-549091